-

Choice to Replace Tedros at WHO Should be Transparent, says AHF

LONDON--(BUSINESS WIRE)--The United Nations Member States will move toward nominating candidates for the post of the next World Health Organization (WHO) Director-General in one month. As the world continues to grapple with the COVID-19 pandemic, the WHO executive election must become more transparent, equitable, merit-based and open to a wide pool of candidates from diverse backgrounds, according to AIDS Healthcare Foundation (AHF), the largest provider of HIV/AIDS care globally.

The current WHO Director-General, Dr. Tedros Adhanom Ghebreyesus, is in the running for the next five-year appointment, but who else is vying for the spot remains hidden from public view, just as much of the selection process has been for years. After the mid-September deadline, the WHO Executive Board will consider all candidates submitted by the Member States and come up with a short list of five names by January 2022. Eventually the Board will whittle down the list to three candidates, before the final decision is voted on by the Member States at the 75th World Health Assembly in May 2022.

“With Dr. Tedros' manifest failure in handling the pandemic, the question is who will replace him? That search must be transparent. We cannot let a decision of this magnitude be made in the dark or be subjected to political maneuvering behind closed doors,” said AHF President Michael Weinstein. “The overriding concern of the Member States and the Executive Board should be to cast the net as wide as possible and seek out leaders from different backgrounds who have the resolve and skills to steer the WHO through this difficult time and restore its reputation as a leading scientific and technical health agency. Public hearings with candidates might be one way to bring more openness to the elections – as constituents of the Member States we have the right to know the process is being carried out fairly and in the interest of global public health.”

In June, AHF published a statement outlining six reasons why Dr. Tedros should not be re-appointed for a second term as Director-General of the WHO. Among the chief concerns about Dr. Tedros’ performance during the pandemic are questions about delays on the part of the WHO in declaring COVID-19 a public health emergency, followed by another delay in declaring it a pandemic, a lack of transparency around the origins of COVID-19, and a general slowness in mounting a robust, clearly articulated response to the pandemic. With the upcoming election of a new Director-General, Member States have an opportunity to address the leadership gap at the WHO by making the search transparent and open to diverse candidates.

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.5 million clients in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare

Contacts

Ged Kenslea, Senior Director, Communications, AHF
+1.323.308.1833 work +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy &
Communications, AHF
+1 323.308.1829
denys.nazarov@ahf.org

AIDS Healthcare Foundation


Release Versions

Contacts

Ged Kenslea, Senior Director, Communications, AHF
+1.323.308.1833 work +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy &
Communications, AHF
+1 323.308.1829
denys.nazarov@ahf.org

Social Media Profiles
More News From AIDS Healthcare Foundation

AHF Hails Introduction of Protect 340B Act of 2026

WASHINGTON--(BUSINESS WIRE)--AHF Hails Introduction of Protect 340B Act of 2026...

AHF Urges African Nations to Take Charge of Medicines Regulation

KIGALI, Rwanda--(BUSINESS WIRE)--With more than 20 African Union Member States yet to ratify the African Medicines Agency (AMA) Treaty, AIDS Healthcare Foundation (AHF) calls on African governments to accelerate ratification and regulatory harmonisation to expand access to affordable medicines and unlock Africa’s pharmaceutical manufacturing potential.The call comes as AMA convenes its inaugural week in Kigali, Rwanda, from 25–30 October 2026, against a backdrop of continued dependence on import...

Treatment = Life: AHF Reaches 2 Million Patients in Care in Africa

KAMPALA, Uganda--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) has surpassed 2 million patients in care across 15 African countries, marking a historic achievement 25 years after beginning its first programs outside the United States in South Africa and Uganda. With programs in four additional countries expected to launch in 2027, AHF is recognizing the communities and partnerships behind this progress while calling for urgent action to close persistent gaps in the HIV response. AHF’s work...
Back to Newsroom